Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Zamuner

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|October 5, 2014
Continuous-time Markov modelling of flexible-dose depression trialsEleonora Marostica, Alberto Russu, Roberto Gomeni, et al.
Proteins|June 3, 2016
Protein-protein structure prediction by scoring molecular dynamics trajectories of putative posesEdoardo Sarti, Ivan Gladich, Stefano Zamuner, et al.
Communications Physics|April 26, 2024
ABC transporters are billion-year-old Maxwell DemonsSolange Flatt, Daniel Maria Busiello, Stefano Zamuner, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 7, 2010
Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patientsRoberto Bizzotto, Stefano Zamuner, Giuseppe De Nicolao, et al.
Proteins|January 11, 2018
Vibrational entropy estimation can improve binding affinity prediction for non-obligatory protein complexesTatjana Škrbić, Stefano Zamuner, Rolando Hong, et al.
Biophysical Journal|October 27, 2019
Mechanics of Allostery: Contrasting the Induced Fit and Population Shift ScenariosRiccardo Ravasio, Solange Marie Flatt, Le Yan, et al.
Sleep|August 2, 2012
The orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomniaPaolo Bettica, Lisa Squassante, Stefano Zamuner, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 16, 2014
Population model of longitudinal FEV1 data in asthmatics: meta-analysis and predictability of placebo responseEleonora Marostica, Alberto Russu, Shuying Yang, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 12, 2018
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issuesSilvia Maria Lavezzi, Enrica Mezzalana, Stefano Zamuner, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 23, 2018
Time-to-Event Modeling of Left- or Right-Censored Toxicity Data in Nonclinical Drug ToxicologyAlienor Berges, Marc Cerou, Tarjinder Sahota, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Journal of Pharmacokinetics and Pharmacodynamics|October 5, 2014
Continuous-time Markov modelling of flexible-dose depression trialsEleonora Marostica, Alberto Russu, Roberto Gomeni, et al.
Proteins|June 3, 2016
Protein-protein structure prediction by scoring molecular dynamics trajectories of putative posesEdoardo Sarti, Ivan Gladich, Stefano Zamuner, et al.
Communications Physics|April 26, 2024
ABC transporters are billion-year-old Maxwell DemonsSolange Flatt, Daniel Maria Busiello, Stefano Zamuner, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 7, 2010
Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patientsRoberto Bizzotto, Stefano Zamuner, Giuseppe De Nicolao, et al.
Proteins|January 11, 2018
Vibrational entropy estimation can improve binding affinity prediction for non-obligatory protein complexesTatjana Škrbić, Stefano Zamuner, Rolando Hong, et al.
Biophysical Journal|October 27, 2019
Mechanics of Allostery: Contrasting the Induced Fit and Population Shift ScenariosRiccardo Ravasio, Solange Marie Flatt, Le Yan, et al.
Sleep|August 2, 2012
The orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomniaPaolo Bettica, Lisa Squassante, Stefano Zamuner, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 16, 2014
Population model of longitudinal FEV1 data in asthmatics: meta-analysis and predictability of placebo responseEleonora Marostica, Alberto Russu, Shuying Yang, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 12, 2018
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issuesSilvia Maria Lavezzi, Enrica Mezzalana, Stefano Zamuner, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 23, 2018
Time-to-Event Modeling of Left- or Right-Censored Toxicity Data in Nonclinical Drug ToxicologyAlienor Berges, Marc Cerou, Tarjinder Sahota, et al.
Pageof 5